Element Wealth’s AbbVie ABBV Stock Holding History

Element Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Sell	5,482 -68	-1%	-$14.6K	0.52%	51
2026 Q1	$1.21M	Sell	5,550 -10	-0.2%	-$2.22K	0.5%	54
2025 Q4	$1.27M	Buy	5,560 +76	+1%	+$17.3K	0.52%	50
2025 Q3	$1.27M	Buy	5,484 +166	+3%	+$33.8K	0.55%	47
2025 Q2	$987K	Buy	5,318 +12	+0.2%	+$2.23K	0.45%	52
2025 Q1	$1.11M	Sell	5,306 -99	-2%	-$19.2K	0.6%	40
2024 Q4	$960K	Buy	5,405 +77	+1%	+$14.2K	0.5%	39
2024 Q3	$1.05M	Sell	5,328 -39	-0.7%	-$7.28K	0.56%	37
2024 Q2	$921K	Buy	5,367 +10	+0.2%	+$1.66K	0.52%	40
2024 Q1	$976K	Buy	5,357 +7	+0.1%	+$1.21K	0.57%	36
2023 Q4	$829K	Sell	5,350 -40	-0.7%	-$5.83K	0.52%	37
2023 Q3	$803K	Buy	5,390 +14	+0.3%	+$2.06K	0.58%	33
2023 Q2	$724K	Sell	5,376 -67	-1%	-$9.82K	0.5%	37
2023 Q1	$867K	Sell	5,443 -159	-3%	-$24.3K	0.65%	31
2022 Q4	$905K	Sell	5,602 -236	-4%	-$36.2K	0.74%	22
2022 Q3	$783K	Buy	5,838 +36	+0.6%	+$5.17K	0.72%	22
2022 Q2	$889K	Buy	5,802 +81	+1%	+$12.4K	0.88%	21
2022 Q1	$927K	Sell	5,721 -29	-0.5%	-$4.21K	0.75%	22
2021 Q4	$779K	Buy	5,750 +23	+0.4%	+$2.72K	0.59%	28
2021 Q3	$618K	Buy	5,727 +81	+1%	+$9.26K	0.49%	33
2021 Q2	$636K	Buy	5,646 +73	+1%	+$8.22K	0.5%	34
2021 Q1	$603K	Sell	5,573 -26	-0.5%	-$2.78K	0.5%	31
2020 Q4	$600K	Buy	5,599 +23	+0.4%	+$2.21K	0.56%	32
2020 Q3	$488K	Buy	5,576 +52	+0.9%	+$4.9K	0.52%	33
2020 Q2	$542K	Buy	5,524 +296	+6%	+$26.1K	0.62%	28
2020 Q1	$398K	Buy	5,228 +2,056	+65%	+$175K	0.55%	36
2019 Q4	$281K	Buy	+3,172	New	+$263K	0.29%	57

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Element Wealth's ABBV Position: Q2 2026 in Review

Element Wealth reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $14.6K and leaving 5,482 shares worth $1.38M. The position accounts for 0.52% of the portfolio, ranked #51.

Element Wealth first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Element Wealth held 5,482 shares of AbbVie worth $1.38M as of Q2 2026.
Element Wealth sold 68 AbbVie shares in Q2 2026, an estimated $14.6K.
AbbVie made up 0.52% of Element Wealth's portfolio in Q2 2026, its #51 holding.
Element Wealth first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Element Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.